Form 8.3

Summary by AI BETAClose X

An opening position disclosure filed 3 November 2026 reports that as at 2 November 2026 a third-party manager holds 6,618,926 cash-settled derivative references in Advanced Medical Solutions Group, representing 2.995% of the 5p ordinary shares; the filing records two equity-swap reductions of long exposure totaling 1,385 reference securities (841 at £2.83 and 544 at £2.82). The derivatives are cash-settled (no stock-settled positions reported), no indemnities or arrangements were disclosed, and no Supplemental Form 8 was attached.

Disclaimer*

UK 100

Latest directors dealings